Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Immune Thrombocytopenia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02334813
What this trial is testing

Daily Prednisone Versus Pulsed Dexamethasone in Treatment-naïve Adult Patients With Immune Thrombocytopenia

Who this might be right for
Purpura, Thrombocytopenic, Idiopathic
University Hospital, Essen 26
Testing effectiveness (Phase 2)Looking for participantsNCT05599880
What this trial is testing

The Investigate Efficacy and Safety Evaluation of Bortezomib in Patients With Relapsed/Refractory Immune Thrombocytopenia

Who this might be right for
Relapsed/Refractory Immune Thrombocytopenia
Seoul National University Hospital 29
Testing effectiveness (Phase 2)Study completedNCT02153060
What this trial is testing

An Investigation of Dexamethasone With Different Doses in the Management of Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
Shandong University 58
Not applicableLooking for participantsNCT07587723
What this trial is testing

A Real-world Study of Treatment Patterns and Outcomes in Primary Immune Thrombocytopenia Patients Treated With Eltrombopag

Who this might be right for
Immune Thrombocytopenia
Novartis Pharmaceuticals 150
Large-scale testing (Phase 3)Study completedNCT05369208
What this trial is testing

Evaluation of Avatrombopag for the Treatment of Thrombocytopenia in Japanese Adults With Chronic ITP

Who this might be right for
Immune Thrombocytopenia
Sobi, Inc. 19
Large-scale testing (Phase 3)Active Not RecruitingNCT05325593
What this trial is testing

Romiplostim Plus Dexamethasone vs Dexamethasone in Patients With Newly Diagnosed Primary Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 129
Testing effectiveness (Phase 2)Study completedNCT04669600
What this trial is testing

A Phase 2a Study Evaluating BIVV020 in Adults With Persistent/Chronic Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia (ITP)
Bioverativ, a Sanofi company 12
Post-approval studies (Phase 4)Study completedNCT04089267
What this trial is testing

Evaluating the Efficacy and Safety of Different Human Thrombopoietin (rhTPO) Regimens in the Treatment of Patients With Primary Immune Thrombocytopenia (ITP)

Who this might be right for
ITP
Shenyang Sunshine Pharmaceutical Co., LTD. 288
Not applicableNot Yet RecruitingNCT07046013
What this trial is testing

Level of Serum Lactate Dehydrogenase in Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia (ITP)
Sohag University 40
Large-scale testing (Phase 3)Study completedNCT04737850
What this trial is testing

Hetrombopag for Pediatric Patients With Chronic Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Jiangsu HengRui Medicine Co., Ltd. 100
Testing effectiveness (Phase 2)UnknownNCT04797182
What this trial is testing

Avatrombopag for the Primary Prevention of Thrombocytopenia Induced by Cytarabine-based Chemotherapy in Patients With Lymphoma

Who this might be right for
ThrombocytopeniaCytarabine Causing Adverse Effects in Therapeutic UseLymphoma
Sun Yat-sen University 46
Not applicableAvailableNCT07244289
What this trial is testing

Managed Access Programs for VAY736, Ianalumab

Who this might be right for
Primary Immune ThrombocytopeniaSjögren's Syndrome
Novartis Pharmaceuticals
Not applicableLooking for participantsNCT06479317
What this trial is testing

The Efficacy and Safety of HCQ Plus DEX in ANA Positive ITP

Who this might be right for
Immune Thrombocytopenia With Positive ANA Antibodies
Yunfeng Cheng 129
Post-approval studies (Phase 4)UnknownNCT05311930
What this trial is testing

Efficacy and Safety of TPO Receptor Agonists in the Treatment of Elderly ITP Patients

Who this might be right for
Primary Immune Thrombocytopenia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 69
Early research (Phase 1)UnknownNCT04741139
What this trial is testing

Post IVIG Medication in Children With Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Baylor College of Medicine 20
Not applicableUnknownNCT05116423
What this trial is testing

Machine-learning Based Prediction Model in Primary Immune Thrombocytopenia

Who this might be right for
Immune ThrombocytopeniaITP
Peking University People's Hospital 100
Early research (Phase 1)Not Yet RecruitingNCT07599280
What this trial is testing

Universal STAR-T Cell Injection in R/R Autoimmune Diseases.

Who this might be right for
Immune Thrombocytopenia
Jian Zhu 6
Post-approval studies (Phase 4)UnknownNCT05861297
What this trial is testing

Immune Thrombocytopenia Management in Adults

Who this might be right for
Immune Thrombocytopenia Purpura
Nahda University 467
Large-scale testing (Phase 3)UnknownNCT02751593
What this trial is testing

Thrombocytopenia in Gestational Period

Who this might be right for
Immune ThrombocytopeniaPregnancy
Peking University People's Hospital 70
Testing effectiveness (Phase 2)Looking for participantsNCT06853444
What this trial is testing

ESG206 in Patients With Primary Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia (ITP)
Shanghai Escugen Biotechnology Co., Ltd 84
Next Page